Drug
Tenofovir Disoproxil
Tenofovir Disoproxil: highest development phase Phase 2, developed by Gilead Sciences. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Gilead Sciences
Trials
| Drug | Phase | Indication |
|---|---|---|
| tenofovir disoproxil fumarate NCT00270556 | Phase 2 | HIV |
Latest
No recent events.
Follow Tenofovir Disoproxil on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.